Premium
Short Hemodialysis: Long‐Term Mortality and Morbidity
Author(s) -
Wauters JeanPierre,
BerciniPansiot Sylvie,
Gilliard Nicolas,
Stauffer JeanChristophe
Publication year - 1986
Publication title -
artificial organs
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.684
H-Index - 76
eISSN - 1525-1594
pISSN - 0160-564X
DOI - 10.1111/j.1525-1594.1986.tb02541.x
Subject(s) - medicine , hemodialysis , dialysis , nephrology , population , mortality rate , home hemodialysis , dialysis therapy , emergency medicine , pediatrics , intensive care medicine , surgery , environmental health
Individualized short hemodialysis treatment schedules, approximately three 3‐h treatments per week, were introduced in a nephrology unit in 1976. In May 1985, 259 patients had been treated, which corresponds to ˜60 new patients per million inhabitants per year. Ages at start of therapy ranged between 17 and 78 years. Patient survival was 91% at 1 year, 76% at 5 years, and 60% at 10 years. The analysis of causes of death did not show an increase in cardiovascular or infectious problems. Hospitalization rate (excluding hospitalization at start of therapy and vascular access problems) was 7 ± 9 days per patient per year (range 2–161). Therefore, it appears that in a largely unselected dialysis population, a schedule of 3‐h hemodialysis three times per week may be safely applied for at least 9 years. The claim that short hemodialysis is associated with increased mortality and morbidity appears to be based on other interfering factors.